Drug Profile
Ciprofloxacin controlled release - Labopharm
Alternative Names: Ciprofloxacin implant - Labopharm; Controlled-release ciprofloxacin implant - LabopharmLatest Information Update: 04 Dec 2021
Price :
$50
*
At a glance
- Originator Labopharm
- Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bone and joint infections
Most Recent Events
- 30 Oct 2003 Labopharm's controlled-release ciprofloxacin implant is available for licensing (http://labopharm.com)
- 30 Oct 2003 Preclinical trials in Bone and joint infections in Canada (Parenteral)